Paradigm and Bristol Myers Squibb collaborate to build a new model for clinical trials

Paradigm and Bristol Myers Squibb collaborate to build a new model for clinical trials

Source: 
Drugs.com
snippet: 

Paradigm announced today a collaboration with Bristol Myers Squibb to build a new end-to-end clinical trial operating model across design, recruitment, and data collection. Starting with oncology and expanding to other therapeutic areas, Paradigm will enable Bristol Myers Squibb to enroll patients from providers across the Paradigm Network of health systems, all of whom serve diverse groups of patients and already use Paradigm software to reduce the burden of clinical trial recruitment and operations.